Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Apr;191(2):877-884.
doi: 10.1007/s11845-021-02600-8. Epub 2021 Mar 23.

Reminiscence therapy serves as an optional nursing care strategy in attenuating cognitive impairment, anxiety, and depression in acute ischemic stroke patients

Aoyang Li  1 , Yang Liu  2
Affiliations
Randomized Controlled Trial

Reminiscence therapy serves as an optional nursing care strategy in attenuating cognitive impairment, anxiety, and depression in acute ischemic stroke patients

Aoyang Li et al. Ir J Med Sci. 2022 Apr.

Abstract

Background: Reminiscence therapy is revealed to improve cognitive function and attenuate psychological disorders in neurological diseases such as Alzheimer's disease patients, while its application in acute ischemic stroke (AIS) is seldom reported. So, the current study aimed to explore the effect of reminiscence therapy on cognitive impairment, anxiety, depression, and disease recurrence in AIS patients.

Methods: A total of 216 first-ever AIS patients were enrolled and randomized into reminiscence therapy group or control group in 1:1 ratio. MMSE, HADS, and Zung SAS/SDS scales were evaluated at the discharge from hospital (M0), 3 months (M3), 6 months (M6), 9 months (M9), and 12 months (M12), respectively. Besides, patients were further followed up to 36 months for recurrence-free survival (RFS) calculation.

Results: Reminiscence therapy group showed higher MMSE score at M9 and M12, lower cognitive impairment rate by MMSE at M12 compared to control group. As to anxiety, HADS-anxiety score and anxiety rate by HADS were of no difference at each time point, while SAS score and anxiety rate by SAS were lower at M12 in reminiscence therapy group compared with control group. Regarding depression, HADS-depression score and depression rate by HADS at M12, SDS score at M9 and M12, and depression rate by SDS at M12 were all lower in reminiscence therapy group compared with control group. In terms of RFS, it was similar between reminiscence therapy group and control group.

Conclusion: Reminiscence therapy cripples cognitive impairment, anxiety, and depression, but does not affect RFS in AIS patients, indicating its potential for post-stroke management.

Keywords: Acute ischemic stroke; Anxiety; Cognitive impairment; Depression; Reminiscence therapy.

PubMed Disclaimer

References

    1. Phipps MS, Cronin CA (2020) Management of acute ischemic stroke. BMJ 368:l6983 - DOI
    1. Chowdhury SZ, Santana Baskar P, Bhaskar S et al (2021) Effect of pre-hospital workflow optimization on treatment delays and clinical outcomes in acute ischemic stroke: a systematic review and meta-analysis. Acad Emerg Med
    1. Muresanu DF, Strilciuc S, Stan A et al (2019) Current drug treatment of acute ischemic stroke: challenges and opportunities. CNS Drugs 33(9):841–847 - DOI
    1. Rabinstein AA (2020) Update on treatment of acute ischemic stroke. Continuum (Minneap Minn) 26(2):268–286
    1. Zhang S, Xu M, Liu ZJ et al (2020) Neuropsychiatric issues after stroke: clinical significance and therapeutic implications. World J Psychiatry 10(6):125–138 - DOI

Publication types

LinkOut - more resources